SLR Investment SLRC Surges 232 Nearing 1389 Resistance 20260515 Avalo AVTX Q1 2026 Earnings Surprise EPS 098 Up Significant Future Money Acquisition Corp Files Form 8K What Investors Should Know Prudential to Acquire 75 Stake in Bharti Life for 3500 Crore Bloom Energy Surges 12 on 26 Billion AI Data Center Deal with Nebius Delivery Hero Shares Surge on Potential Uber Takeover Offer Infrastructure Control Could Become the Next Frontier for Financial Edge Telangana Cabinet Approves New Life Sciences Policy 202630 with RD Incentives US Retail Sales Growth Slows as Consumer Sentiment Dips on Labor Market Concerns Novartis Raises FullYear Sales and Profit Outlook Signaling Strong Operating Momentum BK Q1 2026 Earnings EPS Surpasses Estimates by 133 Revenue Details Not Disclosed WHLRL Q2 2024 Earnings Unanticipated EPS Surge Amid Limited Disclosure Harrow Inc HROW Q1 2026 Earnings Significant EPS Miss Amid Operating Challenges MPLT Q1 2026 Earnings WiderThanExpected Loss and Stock Decline Amid ClinicalStage Pipeline Development NSA Q1 2026 Earnings SelfStorage REIT Beats EPS Estimates Despite Modest Stock Decline STAG Q1 2026 Earnings Industrial REIT Surpasses EPS Estimates by a Wide Margin FG Imperii Warrants FGIIW Hold Steady at 025 Key Levels in Focus NPK International Inc NPKI Edges Lower Amid Modest Pullback Norfolk Southern NSC Gains 18 as Railroad Stock Holds Above Key Support Patriot National Bancorp PNBK Drops 637 as Shares Press Key 090 Support Newbridge Acquisition Limited NBRG Holds Steady Near Resistance After Minor Dip CHRS Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares FNLC Q1 2026 Earnings EPS of 080 Reported Amid Quiet Quarter VUZI Q1 2026 Earnings EPS Beat but Revenue Uncertainty Lingers CYTK Q1 2026 Earnings Narrower Loss Boosts Investor Confidence but Stock Falters DHCNI Q1 2026 Earnings EPS Misses Expectations Amid Challenging Real Estate Market Estate Transparency Concerns What Beneficiaries Can Do When a Trustee Refuses to Account HUIZ Q1 2025 Earnings Significant EPS Miss as Company Reports Wide Loss AN2 Therapeutics ANTX Slides 27 as Shares Test Support Near 427